The detection of designer drugs requires advanced analytical techniques such as mass spectrometry and gas chromatography. These methods can identify the unique chemical fingerprints of designer drugs. However, continuous updates to databases are essential to include newly emerging substances, ensuring accurate identification and quantification.
